.png)
Consumers who purchased testosterone gel manufactured by Strides Pharma Inc. for personal or household use in the United States between June 1, 2022, and July 31, 2025, may be eligible to claim a cash payment from a class action settlement.
Strides Pharma Inc. agreed to resolve a class action lawsuit alleging its testosterone gel contained excessive levels of benzene, a chemical classified as a human carcinogen. The plaintiffs claim the benzene presence rendered the product economically worthless or worth less than what consumers paid.
Who can file a claim?
Class members must meet the following requirements:
- They are a natural person (not a business or organization).
- They purchased Strides testosterone gel for personal or household use.
- They purchased the gel in the United States between June 1, 2022, and July 31, 2025.
How much can class members receive?
The amount a class member can receive depends on when they purchased the Strides testosterone gel and how much they paid out of pocket for each prescription.
- Purchases from Jan. 1, 2025, to July 31, 2025: 100% reimbursement of out-of-pocket payments per prescription
- Purchases from Jan. 1, 2024, to Dec. 31, 2024: 75% reimbursement of out-of-pocket payments per prescription
- Purchases from June 1, 2022, to Dec. 31, 2023: 40% reimbursement of out-of-pocket payments per prescription
- Minimum payment: For any prescription in which the class member's out-of-pocket payment was less than $3.50, the settlement administrator will set the baseline to $3.50 and adjust it by the percentage for the purchase date.
If the total value of all approved claims is less than $750,000, the settlement administrator will distribute the remaining funds pro rata among claimants based on the value of their claims. If the total value of claims exceeds $750,000, each claimant will still receive the calculated reimbursement amount as described above.
How to claim a class action
Class members will be able to submit an online claim or download and print a PDF claim form to complete and mail to the settlement administrator. These options are not yet available on the settlement website.
Settlement administrator's mailing address: Painter v. Strides Pharma Inc. Settlement, P.O. Box 301134, Los Angeles, CA 90030-1134
Is proof or documentation required to submit a claim?
Yes. Claimants must provide proof of purchase for each prescription of Strides testosterone gel they bought during the class period. Acceptable documentation includes:
- Pharmacy, insurance or pharmacy benefits manager records showing the required details
- Original or copy of the purchase receipt
Acceptable documentation must show:
- The identity of the purchaser
- The date of purchase
- The product’s National Drug Code, such as 64380015102 or 64380015202, or other manufacturer identification confirming the purchase as Strides testosterone gel
- The amount paid out of pocket, if any
Payout options
The settlement does not provide specific payment information.
Settlement fund breakdown
The settlement fund includes:
- Settlement administration costs: To be determined
- Attorneys' fees and costs: To be determined
- Service awards to class representatives: To be determined
- Payments to eligible class members: At least $750,000
Important dates
- Exclusion (opt-out) deadline: Aug. 17, 2026
- Deadline to file a claim: Sept. 16, 2026
- Fairness hearing: Nov. 19, 2026
When is the Strides testosterone gel settlement payout date?
The settlement administrator will issue payments after the court resolves any appeals and grants final approval of the settlement.
Why is there a class action settlement?
The class action lawsuit alleges Strides Pharma Inc. manufactured and distributed testosterone gel containing benzene, a substance classified as a human carcinogen. The plaintiffs claim the presence of benzene made the product unlawful to sell and economically worthless, resulting in financial loss to purchasers.
Strides denies these allegations but agreed to settle the case to avoid the expense, risk and delay of further litigation. As part of the settlement, Strides also reformulated its product and agreed to ongoing testing to ensure future products do not contain benzene above regulatory limits.
.webp)
.webp)
.webp)
.webp)
.webp)
.webp)
.webp)
.svg)